Article Versions Notes

Else L, Penchala SD, Pillay A-D, Seiphetlo TB, Lebina L, Callebaut C, Minhas S, Morley R, Rashid T, Martinson N, et al. Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue. Pharmaceutics. 2022; 14(6):1285. https://doi.org/10.3390/pharmaceutics14061285

Else, Laura, Sujan D. Penchala, Azure-Dee Pillay, Thabiso B. Seiphetlo, Limakatso Lebina, Christian Callebaut, Suks Minhas, Roland Morley, Tina Rashid, Neil Martinson, and et al. 2022. "Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue" Pharmaceutics 14, no. 6: 1285. https://doi.org/10.3390/pharmaceutics14061285

Else, L., Penchala, S. D., Pillay, A.-D., Seiphetlo, T. B., Lebina, L., Callebaut, C., Minhas, S., Morley, R., Rashid, T., Martinson, N., Fox, J., Khoo, S., & Herrera, C., on behalf of the CHAPS Consortium. (2022). Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue. Pharmaceutics, 14(6), 1285. https://doi.org/10.3390/pharmaceutics14061285